Blockade of Leukotriene B4 Signaling Pathway Induces Apoptosis and Suppresses Cell Proliferation in Colon Cancer

DOI Web Site PubMed 被引用文献7件 参考文献45件 オープンアクセス
  • Ihara Aya
    Department of Gastroenterology, Yokohama City University Graduate School of Medicine, Japan
  • Wada Koichiro
    Department of Pharmacology, Graduate School of Dentistry, Osaka University, Japan
  • Yoneda Masato
    Division of Gastroenterology, Yokohama City University School of Medicine, Japan
  • Fujisawa Nobutaka
    Division of Gastroenterology, Yokohama City University School of Medicine, Japan
  • Takahashi Hirokazu
    Division of Gastroenterology, Yokohama City University School of Medicine, Japan
  • Nakajima Atsushi
    Division of Gastroenterology, Yokohama City University School of Medicine, Japan

書誌事項

公開日
2007
DOI
  • 10.1254/jphs.fp0060651
公開者
公益社団法人 日本薬理学会

この論文をさがす

説明

We investigated whether leukotriene B4 (LTB4) and its signaling pathway play an important role in the progression of human colon cancer via a direct stimulation of cancer cell proliferation. Remarkable expression of LTB4 receptor 1 (BLT1) in human colon cancer tissues was detected by immunohistochemistry, and Western blot analysis revealed the BLT1 expression in cultured human colon cancer cell lines, Caco2 and HT29. The 5-lipoxygenase inhibitor AA-861 and LTB4-receptor antagonist U75302 showed negative effects on survival and proliferation of both Caco2 and HT-29 cells. The inhibition of cell proliferation is due to the apoptosis because nuclear condensation and increased annexin V expression were observed in the cells treated with AA-861 and U75302. Knockdown of BLT1 by small interfering RNA caused the suppression of BLT1 protein, resulting in the inhibition of cancer cell proliferation. Blockade of BLT1 by the receptor antagonist significantly suppresses the LTB4-stimulated extracellular signal-regulated kinase (ERK) activation in colon cancer cells. These results indicate that the blockade of the LTB4-signaling pathway induces apoptosis via the inhibition of ERK activation in colon cancer cells. The LTB4-signaling pathway might be a new therapeutic target for colon cancer.<br>

収録刊行物

被引用文献 (7)*注記

もっと見る

参考文献 (45)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ